Join the Seizures group to help and get support from people like you.
Seizures News (Page 3)
Related terms: Complex Partial Seizure, Fits, Convulsion, Absence Seizure
Teens With Epilepsy Face Higher Odds for Eating Disorders
MONDAY, Dec. 4, 2023 – Teenagers with epilepsy are more likely to have an eating disorder than those not suffering from the brain disease, a new study shows. About 8.4% of children ages 10 to 19...
Deployment History Has Differential Impact on Epilepsy in Veterans With TBI
THURSDAY, Nov. 30, 2023 – For veterans with traumatic brain injury (TBI), deployment history has a significant differential impact on epilepsy predictors, according to a study published online Nov....
Yoga Intervention Can Reduce Felt Stigma in Epilepsy Patients
THURSDAY, Nov. 9, 2023 – For patients with epilepsy, yoga therapy plus psychoeducation can reduce felt stigma, according to a study published online Nov. 8 in Neurology. Kirandeep Kaur, Ph.D., from...
Could You Recognize the More Subtle Signs of a Seizure?
THURSDAY, Nov. 2, 2023 – A seizure doesn’t always look like what you see in the movies, but a new survey finds most Americans don't know what the more subtle signs of seizures are. “Anything that int...
Novel Potassium Channel Opener Safe, Effective for Adults With Focal Epilepsy
WEDNESDAY, Oct. 11, 2023 – XEN1101 appears safe and effective for the treatment of focal-onset seizures (FOSs), according to results of a phase 2b study published online Oct. 9 in JAMA Neurology....
Experimental Drug XEN1101 Could Rein in Epilepsy Seizures
TUESDAY, Oct. 10, 2023 – For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them....
Mitch McConnell's Recent Episodes Weren't Strokes or Seizures, Capitol Doc Says
TUESDAY, Sept. 5, 2023 – The two "freezing" episodes that Sen. Mitch McConnell experienced recently weren't strokes or seizures, the Capitol physician said in a new letter released Tuesday. “My e...
Taking Kratom Claimed Her Son's Life. Now She and Others Are Warning of the Dangers
THURSDAY, Aug. 3, 2023 – J.D. Butler was planning a future with his girlfriend at his favorite New York City restaurant when that future came to a sudden, crushing halt. “They were planning on when s...
FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures
First and only product approved for treating seizures in neonatal patients Mumbai, India, November 18, 2022 – Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. t...
FDA Approves Zonisade (zonisamide oral suspension) for the Treatment of Partial-Onset Seizures
The first and only FDA-approved zonisamide oral liquid formulation WOBURN, Mass., July 18, 2022 /PRNewswire/ – Azurity Pharmaceuticals, Inc., a private pharmaceutical company focused on developing...
Fintepla (fenfluramine) Oral Solution Now FDA Approved for Treatment of Seizures Associated with Lennox-Gastaut Syndrome (LGS)
Fintepla® has demonstrated efficacy in the most difficult-to-treat seizure types,1,2 including drop seizures, which cause a person to suddenly lose muscle tone, become limp, and fall to the ground, ...
FDA Approves Ztalmy (ganaxolone) for Seizures Associated with CDKL5 Deficiency Disorder
RADNOR, Pa.--(BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today...
FDA Medwatch Alert: Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Levetiracetam Injection, USP Due to Lack of Sterility Assurance
CHICAGO, IL – November 19, 2021 - Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of four lots of Levetiracetam Injection, USP, to the user level. The lack of container c...
UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
ATLANTA, Aug. 30, 2021 /PRNewswire/ – UCB announced today that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for Briviact (brivaracetam) CV tablets, oral solution,...
Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy
ATLANTA, Nov. 17, 2020 /PRNewswire/ – UCB, a global pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Vimpat (lacosamide) CV as adjunctive therapy...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related condition support groups
Seizure Prevention, Seizure Prophylaxis, Epilepsy
Related drug support groups
gabapentin, clonazepam, Valium, diazepam, Topamax, lamotrigine, pregabalin, Depakote, topiramate, view more... Keppra, progesterone, Trileptal, oxcarbazepine, levetiracetam, phenobarbital, Vimpat